Contact

You can leave a message using the contact form below.

(+34) 622 243 606

Information: info@leadartis.com
Business development : licensing@leadartis.com

QUBE Technology Park

Calle de Santiago Grisolía, 2
28760 Tres Cantos, Madrid

Latest News

SARS-CoV-2 Spike Trimerbody could represent a therapeutic option for COVID-19.
14-10-2021

We are glad to report that in a recently published EMBO Journal...

"Tumor-targeted costimulatory trimerbodies for cancer Immunotherapy”- A brief discussion with Juan Perez Villar, CEO, LEADARTIS.
07-06-2021

...

Diario ABC España y Cadena Cope: Investigadores crean un nuevo anticuerpo antitumoral más eficaz
01-06-2021

El director de la unidad de inmunoterapia del cáncer del Instituto de Investigación del Hospital...